Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma.

× No keyword cloud information.

11 in total

Review 1. Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors: Arathi Simha; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina Lindsley
Journal: Cochrane Database Syst Rev Date: 2013-10-02

2. Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF.

Authors: Rajesh K Sharma; Anna T Rogojina; K V Chalam
Journal: Mol Vis Date: 2010-10-27 Impact factor: 2.367

Review 3. Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors: Arathi Simha; Kanza Aziz; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina B Lindsley
Journal: Cochrane Database Syst Rev Date: 2020-02-06

4. Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.

Authors: Raluca Rusovici; Monali Sakhalkar; Kakarla V Chalam
Journal: Mol Vis Date: 2011-12-20 Impact factor: 2.367

5. Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma.

Authors: Anatoly Kuzmin; Dmitry Lipatov; Timofei Chistyakov; Olga Smirnova; Margarita Arbuzova; Alexander Ilin; Marina Shestakova; Ivan Dedov
Journal: Ophthalmol Ther Date: 2013-06-01

6. Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications.

Authors: Lan Liu; Yongfeng Xu; Zhu Huang; Xiaoyu Wang
Journal: BMC Ophthalmol Date: 2016-05-26 Impact factor: 2.209

Review 7. Bevacizumab in Glaucoma: Where do We Stand?

Authors: Anjani Khanna
Journal: J Curr Glaucoma Pract Date: 2012-08-16

8. Suppression of Human Tenon Fibroblast Cell Proliferation by Lentivirus-Mediated VEGF Small Hairpin RNA.

Authors: Zhongqiu Li; Wen Hua; Xuedong Li; Wei Wang
Journal: J Ophthalmol Date: 2017-01-11 Impact factor: 1.909

Review 9. Use of Anti-VEGF Agents in Glaucoma Surgery.

Authors: Mark Slabaugh; Sarwat Salim
Journal: J Ophthalmol Date: 2017-06-27 Impact factor: 1.909

Review 10. Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.

Authors: Vanessa Andrés-Guerrero; Lucía Perucho-González; Julián García-Feijoo; Laura Morales-Fernández; Federico Saenz-Francés; Rocío Herrero-Vanrell; Luis Pablo Júlvez; Vicente Polo Llorens; José María Martínez-de-la-Casa; Anastasios-Georgios Konstas
Journal: Adv Ther Date: 2016-12-20 Impact factor: 3.845